Hims & Hers Health, Inc. reported $2.58B of revenue over the trailing twelve months, +28% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.58B (to Q2 2026). Net income: −$142M, trailing twelve months to Q2 2026. Free cash flow: $62M, trailing twelve months to Q2 2026. Operating margin: −5.6%, trailing twelve months to Q2 2026.

HIMSHims & Hers Health, Inc.

Healthcare

$30.88-47% 1Y

$30.88

$14.5252 weeks$62.76

HIMS as reported

Hims & Hers Health, Inc. reported $2.58B of revenue over the trailing twelve months, +28% on the year before. 10 reported series are charted on this page, each one as filed.

$2.58B

Revenue, trailing twelve months · to Q2 2026 · +28% against the twelve months before

Net income: −$142M
Net income · −173% year on year · trailing twelve months to Q2 2026
Free cash flow: $62M
Free cash flow · −48% year on year · trailing twelve months to Q2 2026
Operating margin: −5.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for HIMS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.58B	+28%	Q2 2026
Net income	−$142M	−173%	Q2 2026
EPS	−$0.63	−180%	Q2 2026
Gross margin	69%	n/a	Q2 2026
Operating margin	−5.6%	n/a	Q2 2026
Net margin	−5.2%	n/a	Q2 2026
ROE	−0.01%	n/a	Q2 2026
ROA	1.9%	n/a	Q2 2026
Free cash flow	$62M	−48%	Q2 2026
P/E	69.3	n/a	Q4 2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.